Open access · CC-BY
via OpenAlex
Mitochondrial Telomerase Protects Cancer Cells from Nuclear DNA Damage and Apoptosis
Chatchawan Singhapol, Deepali Pal, Rafal Czapiewski, Mahendar Porika, Glyn Nelson, Gabriele Saretzki
PLoS ONE · 2013 · ▲ 193 citations
Genomic instability
Telomere attrition
Mitochondrial dysfunction
Stem-cell exhaustion
Telomerase activation
Cell culture / in vitro
Abstract
Most cancer cells express high levels of telomerase and proliferate indefinitely. In addition to its telomere(definition) maintenance function, telomerase also has a pro-survival function resulting in an increased resistance against DNA damage and decreased apoptosis induction. However, the molecular mechanisms for this protective function remain elusive and it is unclear whether it is connected to telomere maintenance or is rather a non-telomeric function of the telomerase protein, TERT. It was shown recently that the protein subunit of telomerase can shuttle from the nucleus to the mitochondria upon oxidative stress where it protects mitochondrial function and decreases intracellular oxidative stress. Here we show that endogenous telomerase (TERT protein) shuttles from the nucleus into mitochondria upon oxidative stress in cancer cells and analyzed the nuclear exclusion patterns of endogenous telomerase after treatment with hydrogen peroxide in different cell lines. Cell populations excluded TERT from the nucleus upon oxidative stress in a heterogeneous fashion. We found a significant correlation between nuclear localization of telomerase and high DNA damage, while cells which excluded telomerase from the nucleus displayed no or very low DNA damage. We modeled nuclear and mitochondrial telomerase using organelle specific localization vectors and confirmed that mitochondrial localization of telomerase protects the nucleus from inflicted DNA damage and apoptosis while, in contrast, nuclear localization of telomerase correlated with higher amounts of DNA damage and apoptosis. It is known that nuclear DNA damage can be caused by mitochondrially generated reactive oxygen species (ROS). We demonstrate here that mitochondrial localization of telomerase specifically prevents nuclear DNA damage by decreasing levels of mitochondrial ROS. We suggest that this decrease of oxidative stress might be a possible cause for high stress resistance of cancer cells and could be especially important for cancer stem cells.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0052989
- Canonical
- link ↗
- Fetched
- 2026-06-22 MST
Cite this
APA
Singhapol, C., Pal, D., Czapiewski, R., Porika, M., Nelson, G., & Saretzki, G. (2013). Mitochondrial Telomerase Protects Cancer Cells from Nuclear DNA Damage and Apoptosis. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0052989
Vancouver
Singhapol C, Pal D, Czapiewski R, Porika M, Nelson G, Saretzki G. Mitochondrial Telomerase Protects Cancer Cells from Nuclear DNA Damage and Apoptosis. PLoS ONE. 2013. doi:10.1371/journal.pone.0052989.
BibTeX
@article{chatchawan2013Mitoch,
title = {Mitochondrial Telomerase Protects Cancer Cells from Nuclear DNA Damage and Apoptosis},
author = {Chatchawan Singhapol and Deepali Pal and Rafal Czapiewski and Mahendar Porika and Glyn Nelson and Gabriele Saretzki},
journal = {PLoS ONE},
year = {2013},
doi = {10.1371/journal.pone.0052989},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biochimie 1999
Citation only
Oxidative DNA damage processing in nuclear and mitochondrial DNA
Cardiovascular Research 2006
Open access · OA
DNA damage and repair in atherosclerosis
International Journal of Molecular Sciences 2013
Open access · CC-BY
Mitochondrial and Nuclear DNA Damage and Repair in Age-Related Macular Degeneration
Metabolites 2023
Open access · CC-BY
Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells
Human Molecular Genetics 2011
Open access · OA
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage
Current Cancer Drug Targets 2022
Preprint · OA